Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.

Abstract : The development of a prophylactic vaccine against hepatitis C virus (HCV) has become an important medical priority, because 3-4 million new HCV infections are thought to occur each year worldwide. Hepatitis B virus (HBV) is another major human pathogen, but infections with this virus can be prevented with a safe, efficient vaccine, based on the remarkable ability of the envelope protein (S) of this virus to self-assemble into highly immunogenic subviral particles. Chimeric HBV-HCV envelope proteins in which the N-terminal transmembrane domain of S was replaced with the transmembrane domain of the HCV envelope proteins (E1 or E2) were efficiently coassembled with the wild-type HBV S protein into subviral particles. These chimeric particles presented the full-length E1 and E2 proteins from a genotype 1a virus in an appropriate conformation for formation of the E1-E2 heterodimer. Produced in stably transduced Chinese hamster ovary cells and used to immunize New Zealand rabbits, these particles induced a strong specific antibody (Ab) response against the HCV and HBV envelope proteins in immunized animals. Sera containing anti-E1 or anti-E2 Abs elicited by these particles neutralized infections with HCV pseudoparticles and cell-cultured viruses derived from different heterologous 1a, 1b, 2a, and 3 strains. Moreover, the anti-hepatitis B surface response induced by these chimeric particles was equivalent to the response induced by a commercial HBV vaccine. Conclusions: Our results provide support for approaches based on the development of bivalent HBV-HCV prophylactic vaccine candidates potentially able to prevent initial infection with either of these two hepatotropic viruses. (HEPATOLOGY 2013).
Type de document :
Article dans une revue
Hepatology, Wiley-Blackwell, 2013, 57 (4), pp.1303-13. 〈10.1002/hep.26132〉
Liste complète des métadonnées

Littérature citée [17 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00812948
Contributeur : Philippe Roingeard <>
Soumis le : samedi 1 février 2014 - 07:00:20
Dernière modification le : mercredi 21 mars 2018 - 10:54:08
Document(s) archivé(s) le : lundi 5 mai 2014 - 10:47:35

Fichiers

Hepatology_Beaumont_2013.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Elodie Beaumont, Romuald Patient, Christophe Hourioux, Isabelle Dimier-Poisson, Philippe Roingeard. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.. Hepatology, Wiley-Blackwell, 2013, 57 (4), pp.1303-13. 〈10.1002/hep.26132〉. 〈inserm-00812948〉

Partager

Métriques

Consultations de la notice

835

Téléchargements de fichiers

501